P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
0.440
+0.012 (2.90%)
At close: Oct 22, 2024, 4:00 PM
0.441
+0.001 (0.14%)
Pre-market: Oct 23, 2024, 7:03 AM EDT
P3 Health Partners Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 1,403 | 1,266 | 1,049 | 637.36 | 491.06 | 145.48 |
| Revenue Growth (YoY) | 23.31% | 20.67% | 64.66% | 29.79% | 237.54% | - |
| Cost of Revenue | 1,394 | 1,235 | 1,057 | 659.34 | 484.5 | 141.03 |
| Gross Profit | 8.73 | 31.64 | -7.75 | -21.98 | 6.56 | 4.45 |
| Selling, General & Admin | 113.62 | 125.6 | 162.38 | 119.41 | 54.89 | 37.23 |
| Other Operating Expenses | -18.23 | -12.71 | -11.46 | 37.84 | -20.54 | 6.36 |
| Operating Expenses | 181.98 | 199.57 | 238.21 | 165.97 | 35.15 | 43.99 |
| Operating Income | -173.25 | -167.93 | -245.96 | -187.95 | -28.59 | -39.54 |
| Interest Expense | -17.74 | -15.99 | -11.4 | -10.68 | -2.53 | -2.53 |
| Other Non Operating Income (Expenses) | 11.43 | 0.18 | 12.62 | -5.72 | -0.29 | 0.1 |
| EBT Excluding Unusual Items | -179.56 | -183.73 | -244.74 | -204.34 | -31.41 | -41.97 |
| Impairment of Goodwill | - | - | -1,315 | - | - | - |
| Pretax Income | -179.56 | -183.73 | -1,560 | -204.34 | -31.41 | -41.97 |
| Income Tax Expense | 5.22 | 2.7 | 1.86 | - | - | - |
| Earnings From Continuing Operations | -184.78 | -186.43 | -1,562 | -204.34 | -31.41 | -41.97 |
| Minority Interest in Earnings | 115.3 | 128.65 | 1,291 | 47.86 | - | - |
| Net Income | -69.48 | -57.77 | -270.13 | -156.48 | -31.41 | -41.97 |
| Preferred Dividends & Other Adjustments | - | - | - | -146.4 | - | - |
| Net Income to Common | -69.48 | -57.77 | -270.13 | -10.08 | -31.41 | -41.97 |
| Shares Outstanding (Basic) | 121 | 95 | 42 | 42 | 66 | 48 |
| Shares Outstanding (Diluted) | 121 | 295 | 42 | 42 | 66 | 48 |
| Shares Change (YoY) | 108.88% | 608.51% | - | -36.84% | 38.34% | - |
| EPS (Basic) | -0.57 | -0.61 | -6.50 | -0.24 | -0.48 | -0.88 |
| EPS (Diluted) | -1.20 | -0.63 | -6.50 | -0.24 | -0.48 | -0.88 |
| Free Cash Flow | -53.91 | -77.86 | -128.25 | -69.88 | -27.52 | -29.74 |
| Free Cash Flow Per Share | -0.44 | -0.26 | -3.08 | -1.68 | -0.42 | -0.62 |
| Gross Margin | 0.62% | 2.50% | -0.74% | -3.45% | 1.34% | 3.06% |
| Operating Margin | -12.35% | -13.26% | -23.44% | -29.49% | -5.82% | -27.18% |
| Profit Margin | -4.95% | -4.56% | -25.74% | -1.58% | -6.40% | -28.85% |
| Free Cash Flow Margin | -3.84% | -6.15% | -12.22% | -10.96% | -5.60% | -20.44% |
| EBITDA | -86.66 | -81.26 | -158.67 | -179.22 | -27.79 | -39.14 |
| EBITDA Margin | -6.18% | -6.42% | -15.12% | -28.12% | -5.66% | -26.90% |
| D&A For EBITDA | 86.59 | 86.68 | 87.29 | 8.72 | 0.8 | 0.4 |
| EBIT | -173.25 | -167.93 | -245.96 | -187.95 | -28.59 | -39.54 |
| EBIT Margin | -12.35% | -13.26% | -23.44% | -29.49% | -5.82% | -27.18% |
| Revenue as Reported | 1,403 | 1,266 | 1,049 | 637.36 | 491.06 | 145.48 |
| Advertising Expenses | - | 3.2 | 4.5 | 2.1 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.